Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

Epithelial ovarian cancer (EOC) is the most fatal gynaecological malignancy. Despite initial therapeutic response, the majority of advanced-stage patients relapse and succumb to chemoresistant disease. Overcoming drug resistance is the key to successful treatment of EOC. Members of vascular endothel...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Sci Rep
मुख्य लेखकों: Momeny, Majid, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Eyvani, Haniyeh, Yousefi, Hassan, Mirshahvaladi, Shahab, Poursani, Ensieh M., Barghi, Farinaz, Poursheikhani, Arash, Dardaei, Leila, Bashash, Davood, Ghazi-Khansari, Mahmoud, Tavangar, Seyyed M., Dehpour, Ahmad R., Yaghmaie, Marjan, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382685/
https://ncbi.nlm.nih.gov/pubmed/28383032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep45954
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन